YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...

The first phase of Jharkhand's assembly elections, held on Wednesday, saw a strong turnout of 64.86% across 43 assembl ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

At least four elements appeared intertwined after news recently broke that the much-delayed 2021 Census exercise would begin in early 2025. While the ...

Q3 2024 Earnings Call Transcript November 10, 2024 Operator: Hello and welcome to the Relmada Therapeutics Third Quarter 2024 ...

FDA approval of MIPLYFFATM and product launch cap third quarter filled with multiple commercial and clinical development milestones Zevra ...

PM Modi and Congress President Mallikarjun Kharge urge people to vote in large numbers. Jharkhand Election 2024 highlights: ...

Daré Bioscience, Inc. ( NASDAQ: DARE) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET MarDee Haring-Layton - CAO Sabrina Martucci Johnson - President and CEO ...

Received tentative approval from the FDA for YUTREPIATM (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) ...

More means gaining muscle strength and function in order to maintain independence for basic daily activities such as feeding ... And I guess are you having a pre NDA meeting with the FDA specifically ...

The Lagbaja family head, Pa Tajudeen Lagbaja, has expressed deep regret for obtaining the Nigerian Defence Academy (NDA) form for the late Chief of Army Staff (COAS), Lt. General Taoreed Lagbaja ...

General Taoreed Lagbaja’s family has regretted obtaining Nigerian Defence Academic(NDA) form for the deceased. He said he wouldn’t have obtained the form if he knew his life would be cut short.